Shanghai Fosun Pharmaceutical (02196): The drug registration application for sodium phosphonoformate injection has been approved by the National Medical Products Administration.
Fosun Pharma (02196) announces that its subsidiary Guilin Nan Yue Pharmaceutical Co., Ltd. has received approval from the National Medical Products Administration for the registration of sodium phosphonate injection (referred to as "the drug"). The approved indications for this drug are for the treatment of (1) Cytomegalovirus retinitis in patients with AIDS and (2) Acyclovir-resistant Herpes simplex virus skin and mucous membrane infections in immunocompromised patients.
Shanghai Fosun Pharmaceutical (02196) announced that its holding subsidiary Guilin Nan Pharm Co., Ltd. has received approval from the National Medical Products Administration for the drug registration application of Sodium Foscarnet Injection. The approved indications for this drug include treatment of (1) Cytomegalovirus retinitis in patients with AIDS, and (2) Herpes simplex virus skin and mucous membrane infections in immunocompromised patients.
As of November 2025, the total research and development investment by the group (including the company and its holding subsidiaries/units) for this drug is approximately RMB 4.98 million (unaudited).
According to the latest data from IQVIA CHPA, the sales of Sodium Foscarnet Injection in China (excluding Hong Kong, Macao, and Taiwan) in 2024 were approximately RMB 86.4 million.
The approval of this drug for market will further enrich the product line of the group.
Related Articles
BEISEN HOLDING (09669) spent 1.6969 million Hong Kong dollars to buy back 23,040 shares on December 10th.
Intel Corporation (INTC.US) has had its fine reduced by 1.4 billion euros by the European Court of Justice: the once record-breaking penalty has been reduced.
Data breach affecting over 33 million users, CEO of South Korean e-commerce giant Coupang (CPNG.US) resigns.
BEISEN HOLDING (09669) spent 1.6969 million Hong Kong dollars to buy back 23,040 shares on December 10th.
Intel Corporation (INTC.US) has had its fine reduced by 1.4 billion euros by the European Court of Justice: the once record-breaking penalty has been reduced.
Data breach affecting over 33 million users, CEO of South Korean e-commerce giant Coupang (CPNG.US) resigns.
RECOMMEND
McDonald’s to Evaluate Franchisee Pricing for Customer Value Under Revised Standards
10/12/2025
Baidu’s AI Ace Kunlunxin Prepares For Hong Kong IPO, Domestic Computing Power Faces Crucial Test
08/12/2025
Institutions Say Short-Term Volatility Does Not Alter Upward Trend Of Hong Kong Stocks, Hang Seng Index Still Expected To Challenge 30,000 Points Next Year
08/12/2025
